Back to search

Article

AETA peptide contributes to Alzheimer’s disease signature of synapse dysfunction

2025-08-25

Abstract excerpt

Alzheimer’s disease (AD), the leading cause of dementia, is characterized by early synaptic dysfunction that precedes overt cognitive decline. While amyloid-β and Tau remain central to AD pathogenesis, molecular triggers of synapse weakening remain unclear. Here, we investigated AETA, a novel brain-secreted peptide derived from amyloid precursor protein (APP), as a potential mediator of synapse dysfunction in AD....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c441845a-1be1-530c-b34d-330b90f82aa5
DOI
10.1101/2025.08.22.671719
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AETA peptide contributes to Alzheimer’s disease signature of synapse dysfunctionDOI 10.1101/2025.08.22.671719
Select a neighboring publication to make it the new centre.